Providers' HIV prevention discussions with HIV-seropositive injection drug users

James D. Wilkinson; Wei Zhao; Scott Santibanez; Julia Arnsten; Amy Knowlton; Cynthia A. Gómez; Lisa R. Metsch; Carl Latkin; Amy Knowlton; Karin Tobin; Lisa Metsch; Eduardo Valverde; James Wilkinson; Martina DeVarona; Mary Latka; Dave Vlahov; Phillip Coffin; Marc Gourevitch; Julia Arnsten; Robert Gern; Cynthia Gomez; Kelly Knight; Carol Dawson Rose; Starley Shade; Sonja Mackenzie; David Purcell; Yuko Mizuno; Scott Santibanez; Richard Garfein; Ann O'Leary; Lois Eldred; Kathleen Handley

doi:10.1007/s10461-006-9088-4

Providers' HIV prevention discussions with HIV-seropositive injection drug users

James D. Wilkinson, Wei Zhao, Scott Santibanez, Julia Arnsten, Amy Knowlton, Cynthia A. Gómez, Lisa R. Metsch, Carl Latkin, Amy Knowlton, Karin Tobin, Lisa Metsch, Eduardo Valverde, James Wilkinson, Martina DeVarona, Mary Latka, Dave Vlahov, Phillip Coffin, Marc Gourevitch, Julia Arnsten, Robert GernCynthia Gomez, Kelly Knight, Carol Dawson Rose, Starley Shade, Sonja Mackenzie, David Purcell, Yuko Mizuno, Scott Santibanez, Richard Garfein, Ann O'Leary, Lois Eldred, Kathleen Handley

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Public health agencies have recommended incorporating HIV prevention counseling into the medical care of persons living with HIV/AIDS. Injection drug users (IDUs) especially need HIV risk-reduction counseling because of their high risk for HIV transmission through both sexual and injection behaviors. The objective of this study was to assess the prevalence of, and patient factors associated with, the delivery of HIV prevention messages to HIV-seropositive IDUs in primary care settings. A majority of participants reported having an HIV prevention discussion with their provider during their most recent primary care visit. Factors significantly associated with report of such discussion were being Hispanic or non-Hispanic Black; high school education or less; and better perception of engagement with provider. Medical providers should provide prevention messages to all HIV-seropositive IDUs, regardless of demographic factors. Effective HIV prevention interventions in primary care settings, including interventions to improve patient-provider communication, are needed for HIV-seropositive IDUs.

Original language	English (US)
Pages (from-to)	699-705
Number of pages	7
Journal	AIDS and Behavior
Volume	10
Issue number	6
DOIs	https://doi.org/10.1007/s10461-006-9088-4
State	Published - Nov 2006
Externally published	Yes

Keywords

Acquired immunodeficiency syndrome
Human immunodeficiency virus
Prevention and control
Primary health care
Substance abuse, intravenous

ASJC Scopus subject areas

Social Psychology
Public Health, Environmental and Occupational Health
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10461-006-9088-4

Cite this

Wilkinson, J. D., Zhao, W., Santibanez, S., Arnsten, J., Knowlton, A., Gómez, C. A., Metsch, L. R., Latkin, C., Knowlton, A., Tobin, K., Metsch, L., Valverde, E., Wilkinson, J., DeVarona, M., Latka, M., Vlahov, D., Coffin, P., Gourevitch, M., Arnsten, J., ... Handley, K. (2006). Providers' HIV prevention discussions with HIV-seropositive injection drug users. AIDS and Behavior, 10(6), 699-705. https://doi.org/10.1007/s10461-006-9088-4

Wilkinson, JD, Zhao, W, Santibanez, S, Arnsten, J, Knowlton, A, Gómez, CA, Metsch, LR, Latkin, C, Knowlton, A, Tobin, K, Metsch, L, Valverde, E, Wilkinson, J, DeVarona, M, Latka, M, Vlahov, D, Coffin, P, Gourevitch, M, Arnsten, J, Gern, R, Gomez, C, Knight, K, Rose, CD, Shade, S, Mackenzie, S, Purcell, D, Mizuno, Y, Santibanez, S, Garfein, R, O'Leary, A, Eldred, L & Handley, K 2006, 'Providers' HIV prevention discussions with HIV-seropositive injection drug users', AIDS and Behavior, vol. 10, no. 6, pp. 699-705. https://doi.org/10.1007/s10461-006-9088-4

@article{9881fd990191466c90a451408a2922e6,

title = "Providers' HIV prevention discussions with HIV-seropositive injection drug users",

abstract = "Public health agencies have recommended incorporating HIV prevention counseling into the medical care of persons living with HIV/AIDS. Injection drug users (IDUs) especially need HIV risk-reduction counseling because of their high risk for HIV transmission through both sexual and injection behaviors. The objective of this study was to assess the prevalence of, and patient factors associated with, the delivery of HIV prevention messages to HIV-seropositive IDUs in primary care settings. A majority of participants reported having an HIV prevention discussion with their provider during their most recent primary care visit. Factors significantly associated with report of such discussion were being Hispanic or non-Hispanic Black; high school education or less; and better perception of engagement with provider. Medical providers should provide prevention messages to all HIV-seropositive IDUs, regardless of demographic factors. Effective HIV prevention interventions in primary care settings, including interventions to improve patient-provider communication, are needed for HIV-seropositive IDUs.",

keywords = "Acquired immunodeficiency syndrome, Human immunodeficiency virus, Prevention and control, Primary health care, Substance abuse, intravenous",

author = "Wilkinson, {James D.} and Wei Zhao and Scott Santibanez and Julia Arnsten and Amy Knowlton and G{\'o}mez, {Cynthia A.} and Metsch, {Lisa R.} and Carl Latkin and Amy Knowlton and Karin Tobin and Lisa Metsch and Eduardo Valverde and James Wilkinson and Martina DeVarona and Mary Latka and Dave Vlahov and Phillip Coffin and Marc Gourevitch and Julia Arnsten and Robert Gern and Cynthia Gomez and Kelly Knight and Rose, {Carol Dawson} and Starley Shade and Sonja Mackenzie and David Purcell and Yuko Mizuno and Scott Santibanez and Richard Garfein and Ann O'Leary and Lois Eldred and Kathleen Handley",

note = "Funding Information: Acknowledgments This study was supported by the Centers for Disease Control and Prevention and the Health Resources and Services Administration (CDC/HRSA grant U50CCU317999). We would also like to acknowledge the following people for their contributions to this research: Baltimore: Susan Sherman, Roeina Marvin, Joanne Jenk-ins, Donny Gann, Tonya Johnson. Miami: Clyde McCoy, Rob Malow, Wei Zhao, Lauren Gooden, Sam Comerford, Virginia Locascio, Curtis Delford, Laurel Hall, Henry Boza, Cheryl Riles. New York: George Fesser, Carol Gerran, Diane Thornton. San Francisco: Caryn Pele-grino, Barbara Garcia, Jeff Moore, Erin Rowley, Debra Allen, Dinah Iglesia-Usog, Gilda Mendez, Paula Lum, Greg Austin. Centers for Disease Control and Prevention: Gladys Ibanez, Hae-Young Kim, Toni McWhorter, Jan Moore, Lynn Paxton, John Williamson. Centers for Disease Control and Prevention (Laboratory): Lee Lam, Jeanne Urban, Stephen Soroka, Zilma Rey, Astrid Ortiz, Sheila Bashirian, Marjorie Hubbard, Karen Tao, Bharat Parekh, Thomas Spira.",

year = "2006",

month = nov,

doi = "10.1007/s10461-006-9088-4",

language = "English (US)",

volume = "10",

pages = "699--705",

journal = "AIDS and Behavior",

issn = "1090-7165",

publisher = "Springer New York",

number = "6",

}

TY - JOUR

T1 - Providers' HIV prevention discussions with HIV-seropositive injection drug users

AU - Wilkinson, James D.

AU - Zhao, Wei

AU - Santibanez, Scott

AU - Arnsten, Julia

AU - Knowlton, Amy

AU - Gómez, Cynthia A.

AU - Metsch, Lisa R.

AU - Latkin, Carl

AU - Knowlton, Amy

AU - Tobin, Karin

AU - Metsch, Lisa

AU - Valverde, Eduardo

AU - Wilkinson, James

AU - DeVarona, Martina

AU - Latka, Mary

AU - Vlahov, Dave

AU - Coffin, Phillip

AU - Gourevitch, Marc

AU - Arnsten, Julia

AU - Gern, Robert

AU - Gomez, Cynthia

AU - Knight, Kelly

AU - Rose, Carol Dawson

AU - Shade, Starley

AU - Mackenzie, Sonja

AU - Purcell, David

AU - Mizuno, Yuko

AU - Santibanez, Scott

AU - Garfein, Richard

AU - O'Leary, Ann

AU - Eldred, Lois

AU - Handley, Kathleen

N1 - Funding Information: Acknowledgments This study was supported by the Centers for Disease Control and Prevention and the Health Resources and Services Administration (CDC/HRSA grant U50CCU317999). We would also like to acknowledge the following people for their contributions to this research: Baltimore: Susan Sherman, Roeina Marvin, Joanne Jenk-ins, Donny Gann, Tonya Johnson. Miami: Clyde McCoy, Rob Malow, Wei Zhao, Lauren Gooden, Sam Comerford, Virginia Locascio, Curtis Delford, Laurel Hall, Henry Boza, Cheryl Riles. New York: George Fesser, Carol Gerran, Diane Thornton. San Francisco: Caryn Pele-grino, Barbara Garcia, Jeff Moore, Erin Rowley, Debra Allen, Dinah Iglesia-Usog, Gilda Mendez, Paula Lum, Greg Austin. Centers for Disease Control and Prevention: Gladys Ibanez, Hae-Young Kim, Toni McWhorter, Jan Moore, Lynn Paxton, John Williamson. Centers for Disease Control and Prevention (Laboratory): Lee Lam, Jeanne Urban, Stephen Soroka, Zilma Rey, Astrid Ortiz, Sheila Bashirian, Marjorie Hubbard, Karen Tao, Bharat Parekh, Thomas Spira.

PY - 2006/11

Y1 - 2006/11

N2 - Public health agencies have recommended incorporating HIV prevention counseling into the medical care of persons living with HIV/AIDS. Injection drug users (IDUs) especially need HIV risk-reduction counseling because of their high risk for HIV transmission through both sexual and injection behaviors. The objective of this study was to assess the prevalence of, and patient factors associated with, the delivery of HIV prevention messages to HIV-seropositive IDUs in primary care settings. A majority of participants reported having an HIV prevention discussion with their provider during their most recent primary care visit. Factors significantly associated with report of such discussion were being Hispanic or non-Hispanic Black; high school education or less; and better perception of engagement with provider. Medical providers should provide prevention messages to all HIV-seropositive IDUs, regardless of demographic factors. Effective HIV prevention interventions in primary care settings, including interventions to improve patient-provider communication, are needed for HIV-seropositive IDUs.

AB - Public health agencies have recommended incorporating HIV prevention counseling into the medical care of persons living with HIV/AIDS. Injection drug users (IDUs) especially need HIV risk-reduction counseling because of their high risk for HIV transmission through both sexual and injection behaviors. The objective of this study was to assess the prevalence of, and patient factors associated with, the delivery of HIV prevention messages to HIV-seropositive IDUs in primary care settings. A majority of participants reported having an HIV prevention discussion with their provider during their most recent primary care visit. Factors significantly associated with report of such discussion were being Hispanic or non-Hispanic Black; high school education or less; and better perception of engagement with provider. Medical providers should provide prevention messages to all HIV-seropositive IDUs, regardless of demographic factors. Effective HIV prevention interventions in primary care settings, including interventions to improve patient-provider communication, are needed for HIV-seropositive IDUs.

KW - Acquired immunodeficiency syndrome

KW - Human immunodeficiency virus

KW - Prevention and control

KW - Primary health care

KW - Substance abuse, intravenous

UR - http://www.scopus.com/inward/record.url?scp=33750299125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750299125&partnerID=8YFLogxK

U2 - 10.1007/s10461-006-9088-4

DO - 10.1007/s10461-006-9088-4

M3 - Article

C2 - 16639542

AN - SCOPUS:33750299125

SN - 1090-7165

VL - 10

SP - 699

EP - 705

JO - AIDS and Behavior

JF - AIDS and Behavior

IS - 6

ER -

Providers' HIV prevention discussions with HIV-seropositive injection drug users

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this